| scholarly article | Q13442814 |
| P2093 | author name string | Christina Camell | |
| Emily Goldberg | |||
| Vishwa Deep Dixit | |||
| P2860 | cites work | Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. | Q50870985 |
| Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout. | Q54225782 | ||
| The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils. | Q54331250 | ||
| NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout | Q56797722 | ||
| Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial | Q60057004 | ||
| The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages | Q60687194 | ||
| A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation | Q60998567 | ||
| Ceramide kinase deficiency improves diet-induced obesity and insulin resistance | Q83783188 | ||
| Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 | Q84617958 | ||
| A pilot study of IL-1 inhibition by anakinra in acute gout | Q21195421 | ||
| An overview of sphingolipid metabolism: from synthesis to breakdown | Q24628769 | ||
| Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis | Q24629044 | ||
| Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization | Q24631966 | ||
| CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer | Q24642646 | ||
| IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation | Q24649009 | ||
| Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica | Q24649598 | ||
| Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation | Q24682128 | ||
| The adipokine/ceramide axis: key aspects of insulin sensitization | Q27025041 | ||
| Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
| Mammalian lipoxygenases and their biological relevance | Q28249730 | ||
| Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84 | Q28263047 | ||
| Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes | Q28264518 | ||
| Cryopyrin activates the inflammasome in response to toxins and ATP | Q28291313 | ||
| Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance | Q28291556 | ||
| CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation | Q28506984 | ||
| Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 | Q28507400 | ||
| Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
| Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
| NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
| Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling | Q29616024 | ||
| The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
| Type 2 diabetes as an inflammatory disease | Q29617184 | ||
| CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity | Q29617380 | ||
| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 | ||
| Interleukin-1-receptor antagonist in type 2 diabetes mellitus | Q29619001 | ||
| K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter | Q29620146 | ||
| Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis | Q30538274 | ||
| Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
| Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. | Q33982897 | ||
| Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance | Q34062793 | ||
| Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages | Q34071063 | ||
| Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue | Q34162171 | ||
| Calorie restriction and prevention of age-associated chronic disease. | Q34170610 | ||
| Identification of an adipogenic niche for adipose tissue remodeling and restoration | Q34289690 | ||
| Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages | Q34316035 | ||
| Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
| CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue. | Q34474720 | ||
| Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis | Q34485836 | ||
| Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability | Q34601356 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. | Q34678595 | ||
| Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue | Q34718662 | ||
| The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. | Q34801576 | ||
| The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population | Q34915433 | ||
| Dietary oleic acid increases m2 macrophages in the mesenteric adipose tissue | Q35009952 | ||
| UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis | Q35056779 | ||
| The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease | Q35155012 | ||
| Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux | Q35206149 | ||
| Inflammasome is a central player in the induction of obesity and insulin resistance | Q35216914 | ||
| A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. | Q35350543 | ||
| Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage | Q35417136 | ||
| Regulation of inflammasome activation | Q35456425 | ||
| Visualized macrophage dynamics and significance of S100A8 in obese fat | Q35549380 | ||
| Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry | Q35652442 | ||
| A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity | Q35695494 | ||
| Increased macrophage migration into adipose tissue in obese mice | Q35696560 | ||
| Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection | Q35833796 | ||
| Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice | Q36024453 | ||
| Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. | Q36097975 | ||
| Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice | Q36375776 | ||
| Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice | Q36561831 | ||
| Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages | Q36579422 | ||
| Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages | Q36694157 | ||
| Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity | Q36709603 | ||
| Cellular cholesterol trafficking and compartmentalization | Q37064008 | ||
| Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages | Q37222666 | ||
| Glyburide inhibits the Cryopyrin/Nalp3 inflammasome | Q37387873 | ||
| Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance | Q37656009 | ||
| The IL-1 family: regulators of immunity | Q37676929 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Alternative macrophage activation and metabolism | Q37804862 | ||
| The monocarboxylate transporter family--role and regulation | Q37967617 | ||
| Neutrophils, IL-1β, and gout: is there a link? | Q38076334 | ||
| Mechanisms of NOD-like receptor-associated inflammasome activation | Q38140207 | ||
| Metabolic regulation of immune responses | Q38198155 | ||
| Acyl-CoA metabolism and partitioning | Q38211152 | ||
| Mechanisms and functions of inflammasomes | Q38214128 | ||
| Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. | Q38291637 | ||
| IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance | Q38983262 | ||
| Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses | Q39027982 | ||
| DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. | Q39250720 | ||
| Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism | Q40949635 | ||
| Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption | Q41119321 | ||
| Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. | Q41464597 | ||
| T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice | Q41560139 | ||
| Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation | Q41838863 | ||
| Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression | Q41862754 | ||
| PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells | Q42183814 | ||
| Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages | Q42523070 | ||
| A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. | Q44081169 | ||
| Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. | Q46075227 | ||
| Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice | Q46507912 | ||
| Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. | Q47369917 | ||
| Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance | Q47431942 | ||
| Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice | Q47835280 | ||
| IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. | Q50109905 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammasome complex | Q412405 |
| P304 | page(s) | 334-42 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Seminars in Immunology | Q15762658 |
| P1476 | title | Regulation of Nlrp3 inflammasome by dietary metabolites | |
| P478 | volume | 27 |
| Q99561717 | Gut microbiota, NLR proteins, and intestinal homeostasis |
| Q39236078 | How Factors Involved in the Resolution of Crystal-Induced Inflammation Target IL-1β. |
| Q49501276 | Immunometabolism in 2017: Metabolism and the inflammasome in health and ageing. |
| Q39331486 | Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice. |
| Q39036066 | The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome |
| Q60924142 | The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
Search more.